Instituto Rosenbusch SA
BCBA:ROSE
Instituto Rosenbusch SA
Instituto Rosenbusch SA engages in the manufacture and marketing of veterinary products. The company is headquartered in Buenos Aires, Buenos Aires. The company went IPO on 2008-02-21. The firm's products are structured in two lines: Pharmaceutical, including antibiotics, antimastitics products, antimycotics, antiparasites, vitamins, minerals and other chemotherapies, and Biological, comprising vaccines for cattle, equines, porks and sheeps and dogs. The company is also involved in the slaughtering and provision of meat products. As of December 31, 2011, the Company owned such subsidiaries as Laboratorios Rosenbusch SA, Laboratorios Bolivar SA and Rosenbusch Paraguay SA.
Instituto Rosenbusch SA engages in the manufacture and marketing of veterinary products. The company is headquartered in Buenos Aires, Buenos Aires. The company went IPO on 2008-02-21. The firm's products are structured in two lines: Pharmaceutical, including antibiotics, antimastitics products, antimycotics, antiparasites, vitamins, minerals and other chemotherapies, and Biological, comprising vaccines for cattle, equines, porks and sheeps and dogs. The company is also involved in the slaughtering and provision of meat products. As of December 31, 2011, the Company owned such subsidiaries as Laboratorios Rosenbusch SA, Laboratorios Bolivar SA and Rosenbusch Paraguay SA.
